| Cat.No. | Name | Information |
|---|---|---|
| M54004 | α-CGRP(human) | α-CGRP(human) is a regulatory neuropeptide of 37 amino acids. |
| M53900 | Adrenomedullin (AM) (22-52), human | Adrenomedullin (AM) (22-52), human is an adrenomedullin receptor antagonist, and also antagonizes the calcitonin generelated peptide (CGRP) receptor in the hindlimb vascular bed of the cat. |
| M53230 | Calcitonin Gene Related Peptide (CGRP) II, rat | Calcitonin Gene Related Peptide (CGRP) II, rat, a CGRP receptor activator, is a potent and long-lasting vasodilator. |
| M53229 | Adrenomedullin (11-50), rat | Adrenomedullin (11-50), rat is the C-terminal fragment (11-50) of rat adrenomedullin. |
| M53227 | [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat is a fragments 22-37 of rat calcitonin gene related peptide (CGRP), targeting CGRP receptor and adenylate cyclase. |
| M53226 | Adrenotensin (human) | Adrenotensin (human) (Pro-ADM-153-185 (human)) is a 153-185 fragment of precursor peptide of Adrenomedullin. |
| M53225 | β-CGRP, human | β-CGRP, human (Human β-CGRP) is one of calcitonin peptides, with IC50s of 1 nM and 300 nM for CRLR/RAMP1 and CRLR/RAMP2 in cells. |
| M53224 | Cagrilintide | Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. |
| M50213 | CGRP antagonist 1 | CGRP antagonist 1 is a potent CGRP receptor antagonist with Ki and IC50 values of 1.7 nM and 5.7 nM, respectively. |
| M24777 | Fremanezumab | Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research. |
| M24771 | Eptinezumab | Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults. |
| M24721 | Erenumab | Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine. |
| M22520 | Galcanezumab | Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. |
| M21264 | HTL22562 | HTL22562 is a CGRP antagonist intended for use in studies of acute migraine. |
| M18027 | Chrysin 6-C-glucoside 8-C-arabinoside | Chrysin 6-C-glucoside 8-C-arabinoside |
| M13934 | Olcegepant hydrochloride | Olcegepant hydrochloride (BIBN-4096 hydrochloride) is a potent and selective non-peptide antagonist of the calcitonin gene-related peptide 1 (CGRP1) receptor with IC50 of 0.03 nM and with a Ki of 14.4 pM for human CGRP. |
| M13931 | Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA | Calcitonin Gene Related Peptide (CGRP) (83-119), rat (TFA) is a 37 amino acid calcitonin family of neuropeptide, acts through calcitonin receptor-like receptor (CRLR). |
| M8322 | SB-268262 | SB-268262 is a selective non-peptide antagonist at the CGRP1 receptor. |
| M8169 | SUN B8155 | SUN B8155 is a non-peptide agonist of the calcitonin receptor that selectively mimics the biological effects of calcitonin. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
